Lauren Rusckowski Duprey
Chief Transformation Officer · 4 filings · Latest: Sep 14, 2026
TAKEDA PHARMACEUTICAL CO LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TAK | Lauren Rusckowski Duprey | Chief Transformation Officer | Sep 14, 2026 | Sale | $18.54 | 34,535 | $640.3K | 191,522 | |
TAK | Lauren Rusckowski Duprey | — | Sep 10, 2026 | Proposed Sale | $18.37 | 34,535 | $634.4K | — | |
TAK | Lauren Rusckowski Duprey | Chief Transformation Officer | Aug 10, 2026 | Sale | $17.10 | 47,586 | $813.7K | 226,057 | |
TAK | Lauren Rusckowski Duprey | — | Jul 13, 2026 | Proposed Sale | $16.75 | 51,579 | $863.9K | — | |
TAK | Lauren Rusckowski Duprey | — | Dec 9, 2025 | Proposed Sale | $14.22 | 29,619 | $421.2K | — | |
TAK | Lauren Rusckowski Duprey | — | Jul 9, 2025 | Proposed Sale | $15.42 | 40,919 | $631.0K | — |